Transforming Cannabis Today.
Leading Psychedelics Tomorrow.

Headland aims to become the Caribbean’s leading
plant-based medicinal wellness company
— from cultivation to clinics.

Headland operates two wholly-owned subsidiaries.

WINDICAN-RL_TL-LOGO-small.png

Windican Health owns a 100-acre license to cultivate, manufacture, and export cannabis and related products in St. Vincent and the Grenadines. The company is committed to setting the standard of pharmaceutical-grade, safe and pure medicinal cannabis products in the West Indies and beyond.

cannabis-logo-small.png
 
svg-logo-colour.png

SVG Biomed is dedicated to unlocking the healing power of psychedelics. The company has some of the most comprehensive psychedelic licenses in the industry, including psilocybin, ibogaine, MDMA and other entheogens. SVG Biomed develops pharmaceutical-grade plant-derived products for physician-directed medical care and will have the first clinic permitted for psychiatric treatment using psychedelics.

ibogaine-logo.png
Psylocybin-logo.png
MDMA-logo.png

Headland provides access to plant-based medicines that treat a wide range of conditions.

 

Depression

ADHD

End-of-life distress

Anxiety

Addiction

Neurological problems

PTSD

Pain

Eating disorders

Headland provides access to plant-based medicines that treat a wide range of conditions.

 

Depression

ADHD

End-of-life distress

Anxiety

Addiction

Neurological problems

PTSD

Pain

Eating disorders

Leadership

 
Cy CampbellCEO, Headland Chair, Windican Health

Cy Campbell

CEO, Headland Chair, Windican Health

Robin Alistair LewisVice-Chairman & Co-founder, Headland

Robin Alistair Lewis

Vice-Chairman & Co-founder, Headland

George ScorsisAdvisory Board Chair, Headland

George Scorsis

Advisory Board Chair, Headland

Dr. Carolina Landolt-Marticorena, Medical and Research Advisory Board Chair, Windican Health

Dr. Carolina Landolt-Marticorena

Medical and Research Advisory Board Chair, Windican Health

Dr. Dawn DeCunhaPsychedelics Policy and Applications, SVG Biomed

Dr. Dawn DeCunha

Psychedelics Policy and Applications, SVG Biomed

Chris (Kipp) Bush Cannabis Cultivation Lead, Windican Health

Chris (Kipp) Bush 

Cannabis Cultivation Lead, Windican Health

Leadership

Cy Campbell

CEO, Headland Chair,
Windican Health

Robin Alistair Lewis

Vice-Chairman & Co-founder, Headland

Dr. Carolina Landolt-Marticorena

Medical and Research Advisory Board Chair, Windican Health

George Scorsis

Advisory Board Chair,
Headland

Chris (Kipp) Bush 

Cannabis Cultivation Lead, Windican Health

Dr. Dawn DeCunha

Psychedelics Policy and Applications, SVG Biomed

Caribbean Home, Global Impact

Based in St. Vincent and the Grenadines, this nation offers Headland a competitive advantage to forge a path in the plant-based medicinal wellness space:

  • A Public sector committed to the wellness economy

  • The world’s only completely licensing framework for psychedelics

  • Highest standards for testing and certification

  • Local expertise, effective workforce, and ideal conditions for cultivation

  • Attractive tropical wellness tourism destination

We combine homegrown Vincentian expertise with leading global experts from across North America, Europe, and Asia.

Latest News